There has been a steady decline in death rates among children and adolescent patients diagnosed with cancer (ages 1 to 19 years), minus gender or racial disparity, between 1999 and 2014, according to a new report from the National Center for Health Statistics.
There has been a steady decline in death rates among children and adolescent patients diagnosed with cancer, without gender or racial disparity, between 1999 and 2014, according to a new report released by the National Vital Statistics System of the National Center for Health Statistics. A significant finding of the report is that brain cancer has replaced leukemia as the leading cause of cancer-related death.
Pediatric cancers have seen a steady decline in mortality over the past decade, despite a slow increase in incidence of certain cancer types. For the current report, the researchers evaluated cancer death rates for children between ages 1 and 19 years for the period between 1999 and 2014. They compared death rates for both male and females, as well as white and black children and adolescents. The following are key findings from the report for that period:
Reference
Curtin SC, Miniño AM, Anderson RN. Declines in cancer death rates among children and adolescents in the United States, 1999—2014. NCHS data brief, no 257. Hyattsville, MD: National Center for Health Statistics; 2016.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More